Clinical Trial Results

Showing: All studies [change]
Condition: Cancer Location: Ann Arbor, Michigan 25 trials found
New Search
Filter
Trial Phase
Study Type
EDRN Prostate MRI Biomarker Study
N/AOBSERVATIONAL Ann Arbor, Michigan
RECRUITING
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
PHASE2INTERVENTIONAL Ann Arbor, Michigan
RECRUITING
Childhood Cancer Survivor Study
N/AOBSERVATIONAL Birmingham, Alabama +4 more
RECRUITING
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
PHASE2, PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Pan Tumor Rollover Study
PHASE2INTERVENTIONAL Huntsville, Alabama +4 more
RECRUITING
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
PHASE2INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
N/AOBSERVATIONAL Millville, Delaware +4 more
RECRUITING
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
PHASE2INTERVENTIONAL West Los Angeles, California +4 more
RECRUITING
Prosthesis Guided Speech Rehabilitation of T1/T2 Cancers of the Tongue
NAINTERVENTIONAL Ann Arbor, Michigan
RECRUITING
Collection of Tissue Samples for Cancer Research
N/AOBSERVATIONAL Sacramento, California +4 more
RECRUITING
Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)
PHASE2INTERVENTIONAL Fort Myers, Florida +4 more
RECRUITING
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
PHASE1, PHASE2INTERVENTIONAL Tampa, Florida +4 more
RECRUITING
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
PHASE2INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
PHASE3INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
The Cancer of the Pancreas Screening-5 CAPS5)Study
PHASE3INTERVENTIONAL New Haven, Connecticut +4 more
RECRUITING
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
PHASE2, PHASE3INTERVENTIONAL Long Beach, California +4 more
RECRUITING
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
PHASE2INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
NAINTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
PHASE3INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)
PHASE2INTERVENTIONAL Duarte, California +4 more
RECRUITING
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
PHASE2, PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
PHASE1INTERVENTIONAL Tucson, Arizona +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type